159 related articles for article (PubMed ID: 33443063)
1. A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After
Devasia TP; Dewaraja YK; Frey KA; Wong KK; Schipper MJ
J Nucl Med; 2021 Aug; 62(8):1118-1125. PubMed ID: 33443063
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for
Peterson AB; Mirando DM; Dewaraja YK
EJNMMI Res; 2023 Jun; 13(1):57. PubMed ID: 37306783
[TBL] [Abstract][Full Text] [Related]
3. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in clinical patients and realistic simulations.
Peterson AB; Mirando DM; Dewaraja YK
Res Sq; 2023 Apr; ():. PubMed ID: 37131738
[No Abstract] [Full Text] [Related]
4. Single-Time-Point Imaging for Dosimetry After [
Wang C; Peterson AB; Wong KK; Roseland ME; Schipper MJ; Dewaraja YK
J Nucl Med; 2023 Sep; 64(9):1463-1470. PubMed ID: 37500260
[TBL] [Abstract][Full Text] [Related]
5. Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [
Mansouri Z; Salimi Y; Akhavanallaf A; Shiri I; Teixeira EPA; Hou X; Beauregard JM; Rahmim A; Zaidi H
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1516-1529. PubMed ID: 38267686
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a
Zhao W; Esquinas PL; Frezza A; Hou X; Beauregard JM; Celler A
Phys Med Biol; 2019 Aug; 64(17):175006. PubMed ID: 31287093
[No Abstract] [Full Text] [Related]
7. A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After
Dewaraja YK; Mirando DM; Peterson AB; Niedbala J; Millet JD; Mikell JK; Frey KA; Wong KK; Wilderman SJ; Nelson AS
J Nucl Med; 2022 Nov; 63(11):1665-1672. PubMed ID: 35422445
[TBL] [Abstract][Full Text] [Related]
8. Impact of Single-Time-Point Estimates of
Chicheportiche A; Sason M; Zidan M; Godefroy J; Krausz Y; Gross DJ; Grozinsky-Glasberg S; Ben-Haim S
J Nucl Med; 2023 Oct; 64(10):1610-1616. PubMed ID: 37500259
[TBL] [Abstract][Full Text] [Related]
9. A dosimetry procedure for organs-at-risk in
Marin G; Vanderlinden B; Karfis I; Guiot T; Wimana Z; Reynaert N; Vandenberghe S; Flamen P
Phys Med; 2018 Dec; 56():41-49. PubMed ID: 30527088
[TBL] [Abstract][Full Text] [Related]
10. Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog
Zhang J; Wang H; Jacobson O; Cheng Y; Niu G; Li F; Bai C; Zhu Z; Chen X
J Nucl Med; 2018 Nov; 59(11):1699-1705. PubMed ID: 29653971
[TBL] [Abstract][Full Text] [Related]
11. Dose Mapping After Endoradiotherapy with
Hänscheid H; Lapa C; Buck AK; Lassmann M; Werner RA
J Nucl Med; 2018 Jan; 59(1):75-81. PubMed ID: 28588150
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent
Goetz TI; Lang EW; Prante O; Maier A; Cordes M; Kuwert T; Ritt P; Schmidkonz C
Ann Nucl Med; 2020 Apr; 34(4):244-253. PubMed ID: 32114682
[TBL] [Abstract][Full Text] [Related]
13. Is a single late SPECT/CT based kidney
Beykan S; Tran-Gia J; Borup Jensen S; Lassmann M
Phys Med; 2022 Aug; 100():39-50. PubMed ID: 35724608
[TBL] [Abstract][Full Text] [Related]
14. Bone Marrow Absorbed Doses and Correlations with Hematologic Response During
Hagmarker L; Svensson J; Rydén T; van Essen M; Sundlöv A; Gleisner KS; Gjertsson P; Bernhardt P
J Nucl Med; 2019 Oct; 60(10):1406-1413. PubMed ID: 30902877
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Early Measurements Onto the Estimated Kidney Dose in [(177)Lu][DOTA(0),Tyr(3)]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine Tumors.
Delker A; Ilhan H; Zach C; Brosch J; Gildehaus FJ; Lehner S; Bartenstein P; Böning G
Mol Imaging Biol; 2015 Oct; 17(5):726-34. PubMed ID: 25790773
[TBL] [Abstract][Full Text] [Related]
16. Comparison of voxel S-value methods for personalized voxel-based dosimetry of
Kim KM; Lee MS; Suh MS; Selvam HSMS; Tan TH; Cheon GJ; Kang KW; Lee JS
Med Phys; 2022 Mar; 49(3):1888-1901. PubMed ID: 35014699
[TBL] [Abstract][Full Text] [Related]
17. Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE.
Ilan E; Sandström M; Wassberg C; Sundin A; Garske-Román U; Eriksson B; Granberg D; Lubberink M
J Nucl Med; 2015 Feb; 56(2):177-82. PubMed ID: 25593115
[TBL] [Abstract][Full Text] [Related]
18. Particle filter de-noising of voxel-specific time-activity-curves in personalized
Götz TI; Lang EW; Schmidkonz C; Maier A; Kuwert T; Ritt P
Z Med Phys; 2020 May; 30(2):116-134. PubMed ID: 31859029
[TBL] [Abstract][Full Text] [Related]
19. Personalized kidney dosimetry in
Hou X; Zhao W; Beauregard JM; Celler A
Phys Med Biol; 2019 Aug; 64(17):175004. PubMed ID: 31456584
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
Velikyan I; Sundin A; Sörensen J; Lubberink M; Sandström M; Garske-Román U; Lundqvist H; Granberg D; Eriksson B
J Nucl Med; 2014 Feb; 55(2):204-10. PubMed ID: 24379222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]